Dr. Salahuddin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
508 Fulton Road. Hospital Medicine
Durham, NC 27704- Is this information wrong?
Education & Training
- Duke University School of MedicineMHS-CL, Clinical Leadership, 2010 - 2013
- Duke University HospitalPost-Doctoral Fellowship, Pulmonary toxicity of Bone marrow Transplant patients, 2005 - 2006
- St Louis University School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2005
- University of Illinois College of Medicine at PeoriaResidency, Internal Medicine, 2002 - 2004
- Howard UniversityResidency, Emergency Medicine, 1998 - 2001
- Howard UniversityInternship, Transitional Year, 1997 - 1998
- Dow University of Health SciencesClass of 1994
Certifications & Licensure
- KY State Medical License 2018 - 2025
- NM State Medical License 2019 - 2025
- VA State Medical License 2018 - 2024
- NC State Medical License 2003 - 2024
- IL State Medical License 2002 - 2005
- American Board of Emergency Medicine Emergency Medicine
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Sleep Medicine
Publications & Presentations
PubMed
- 56 citationsRNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.Jing Mi, Xiuwu Zhang, Zahid N. Rabbani, Yingmiao Liu, Srinevas K. Reddy, Zhen Su, F. K. Salahuddin, Kristi D. Viles, Paloma H. Giangrande, Mark W. Dewhirst, Bruce A. S...> ;Molecular Therapy. 2008 Jan 1
- 54 citationsLow molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.Zahid N. Rabbani, F. K. Salahuddin, Pavel S. Yarmolenko, Ines Batinic-Haberle, B. Thrasher, Benjamin Gauter-Fleckenstein, Mark W. Dewhirst, Mitchell S. Anscher, Zeljko...> ;Free Radical Research. 2007 Nov 1
- Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts.Vlahovic, G., Ponce, A. M., Rabbani, Z., Salahuddin, F. K., Zgonjanin, L., Spasojevic, I., Vujaskovic, Z., Dewhirst, M. W.> ;Br J Cancer. 2007 Sep 17
- Join now to see all
Hospital Affiliations
- Randolph HealthAsheboro, North Carolina
- W. G. (Bill) Heffner Veterans Affairs Medical CenterSalisbury, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: